Status:
COMPLETED
Metabolic Surgery for Metabolic Syndrome
Lead Sponsor:
The Third Xiangya Hospital of Central South University
Conditions:
Metabolic Syndrome (MetS)
Hypertension (HTN)
Eligibility:
All Genders
18-65 years
Brief Summary
This study is designed to understand how bariatric surgery affects patients with metabolic syndrome over both the short and long term. We will track changes in blood pressure and other health indicato...
Detailed Description
Metabolic syndrome (MetS) is a combination of obesity, high blood pressure, abnormal blood sugar, and lipid disorders. It greatly increases the risk of heart disease, stroke, and type 2 diabetes. In A...
Eligibility Criteria
Inclusion
- (1) aged 18-65 years; (2) scheduled to undergo bariatric surgery, including laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG); and (3) met the guideline-based indications for surgery at the time of operation.
Exclusion
- (1) coexisting cardiac insufficiency or renal dysfunction; (2) contraindications to bariatric surgery or anesthesia; and (3) refusal to provide informed consent.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
1581 Patients enrolled
Trial Details
Trial ID
NCT07183137
Start Date
September 1 2010
End Date
December 31 2019
Last Update
September 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
Jinshazhou Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China, 510168
3
The third xiangya hospital of Central South University
Changsha, Hunan, China, 410013